Aug 1 |
Biotech Stock Roundup: BMY, GSK, BIIB's Q2 Results, VTVT Down on Setback
|
Aug 1 |
Biogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guidance Raised
|
Aug 1 |
Sage Therapeutics (SAGE) Q2 Loss Wider Than Expected, Sales Rise
|
Aug 1 |
Biogen Q2 Earnings: Beats Consensus, Lifts 2024 Profit Forecast As New Drug Launches Expected To Offset Decline In Multiple Sclerosis Med Sales
|
Aug 1 |
Biogen Stock Slips As Alzheimer's Drug Looks Abroad For Quarterly Beat
|
Aug 1 |
Biogen Lifts Earnings Guidance After Revenue Beats Forecasts
|
Aug 1 |
Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
Aug 1 |
Biogen posts Q2 beat as sales from Alzheimer’s drug pick up
|
Aug 1 |
Biogen Inc. 2024 Q2 - Results - Earnings Call Presentation
|
Aug 1 |
Biogen Inc. (BIIB) Q2 Earnings and Revenues Top Estimates
|